Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Vaginal rings & topical PrEP

Bee Venom Destroys HIV And Spares Surrounding Cells

Editor's pick
HIV / AIDS News From Medical News Today
10 March 2013
People with limited treatment options

New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy

News
10 March 2013
Finance & funding

Funding Scientific Innovation: Global Investments in HIV Treatment Research and Development in 2010 and 2011

Editor's pick
Treatment Action Group
7 March 2013
New & experimental HIV treatments

Can people with resistant HIV omit NRTIs when switching from a failing regimen?

News
7 March 2013
New & experimental HIV treatments

New pro-drug tenofovir alafenamide appears equally effective but better tolerated

News
7 March 2013
New & experimental HIV treatments

New NNRTI MK-1439 shows promise in early clinical trial

News
6 March 2013
New & experimental HIV treatments

Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect

News
6 March 2013
Pharmaceutical industry

GSK wins priority status for new HIV drug in US

Editor's pick
Reuters
18 February 2013
How HIV works

Newly identified natural protein blocks HIV, other deadly viruses

Editor's pick
UCLA press release
12 February 2013
New & experimental HIV treatments

ViiV announces halt to lersivirine development

Editor's pick
HIVandHepatitis.com
7 February 2013
New & experimental HIV treatments

Innovative HIV Gene Therapy Study Soon to Start Enrollment

Editor's pick
TheBody.com
6 February 2013
New & experimental HIV treatments

Suboptimal Suppression with Maraviroc plus a Boosted Protease Inhibitor?

Editor's pick
Journal Watch
5 February 2013
New & experimental HIV treatments

Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide, a Novel Low-Dose Prodrug for the Treatment of HIV

Editor's pick
Gilead press release
25 January 2013
Pharmaceutical industry

Gilead petitions FDA over its Stribild AIDS med

Editor's pick
Pharmalot
25 January 2013
The search for a cure

Pitt team finds 'Achilles Heel' of key HIV replication protein

Editor's pick
Eurekalert (press release)
25 January 2013
The search for a cure

Stanford lab creates HIV-resistant cells

Editor's pick
San Francisco Chronicle
23 January 2013
Treatment outcomes & life expectancy

Australian researchers project that many HIV-positive people will run out of treatment options

News
22 January 2013
New & experimental HIV treatments

Researchers attack HIV's final defenses before drug-resistant mutations emerge

Editor's pick
Medical Xpress
17 January 2013
The search for an HIV prevention vaccine

New insights into HIV vaccine will improve drug development

Editor's pick
Science Daily
11 January 2013
Side effects

FDA clears Salix anti-diarrhoeal for HIV patients

Editor's pick
MarketWatch
2 January 2013
New & experimental HIV treatments

ViiV Files Regulatory Applications for New Integrase Inhibitor Dolutegravir

Editor's pick
AIDSMeds
19 December 2012
New & experimental HIV treatments

ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada

Editor's pick
ViiV press release
18 December 2012
The search for an HIV prevention vaccine

Major Breakthrough in HIV Research: Swiss Vaccine Research Institute

Editor's pick
Business Wire
18 December 2012
HIV treatment for children & young people

DNDi is awarded USD 17.3 million from UNITAID to spur development and delivery of child-adapted ARVs

Editor's pick
Eurekalert Inf Dis
12 December 2012